How do you counsel patients on the risks and benefits of an IL-23 agent versus an IL-17A or IL-17A/F agent?

Both IL-17 and IL-23 agents have demonstrated excellent efficacy for psoriasis. Choosing between them often comes down to access and insurance coverage.
With that being said, considerations include:

1. Side effect profile: The side effect profile for both IL-23 and IL-17 agents is similar, with the exc...

I let patients with severe psoriasis know that both IL-23 and IL-17 blocking drugs are wonderful, both very effective and both very safe. IL-23 drugs don't require as many shots and maybe a touch safer (with less risk of candidiasis and inflammatory bowel disease as near as I can tell). IL-17 drugs ...